These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6236859)

  • 1. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
    Gralnick HR; Williams SB; Coller BS
    Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
    Grainick HR; Williams SB; Coller BS
    J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa.
    Ando B; Wiedmer T; Hamilton KK; Sims PJ
    J Biol Chem; 1988 Aug; 263(24):11907-14. PubMed ID: 3261296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of von Willebrand factor-platelet interaction by fibrinogen.
    Piétu G; Cherel G; Marguerie G; Meyer D
    Nature; 1984 Apr 12-18; 308(5960):648-9. PubMed ID: 6324004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.
    Parker RI; Gralnick HR
    Blood; 1986 Sep; 68(3):732-6. PubMed ID: 3017478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.
    Plow EF; McEver RP; Coller BS; Woods VL; Marguerie GA; Ginsberg MH
    Blood; 1985 Sep; 66(3):724-7. PubMed ID: 3875376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S; Kloczewiak M; Hawiger J
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets have more than one binding site for von Willebrand factor.
    Ruggeri ZM; De Marco L; Gatti L; Bader R; Montgomery RR
    J Clin Invest; 1983 Jul; 72(1):1-12. PubMed ID: 6223940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4.
    McGregor JL; McGregor L; Bauer AS; Catimel B; Brochier J; Dechavanne M; Clemetson KJ
    Eur J Biochem; 1986 Sep; 159(3):443-9. PubMed ID: 2944746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
    Parker RI; Gralnick HR
    Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding.
    Peerschke EI
    Blood; 1992 Feb; 79(4):948-53. PubMed ID: 1737104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.